This company listing is no longer active
Chinook Therapeutics Future Growth
Future criteria checks 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Chinook Therapeutics.
Key information
22.6%
Earnings growth rate
28.0%
EPS growth rate
Biotechs earnings growth | 36.4% |
Revenue growth rate | 63.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 10 Aug 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 80 | -247 | -286 | -253 | 8 |
12/31/2024 | 13 | -284 | -289 | -262 | 11 |
12/31/2023 | 3 | -253 | -290 | -243 | 5 |
6/30/2023 | 6 | -246 | -177 | -174 | N/A |
3/31/2023 | 5 | -216 | -146 | -143 | N/A |
12/31/2022 | 6 | -188 | -119 | -117 | N/A |
9/30/2022 | 57 | -118 | -105 | -103 | N/A |
6/30/2022 | 54 | -92 | -104 | -103 | N/A |
3/31/2022 | 54 | -97 | -101 | -99 | N/A |
12/31/2021 | 52 | -103 | -105 | -103 | N/A |
9/30/2021 | 1 | -160 | -124 | -122 | N/A |
6/30/2021 | 1 | -149 | -105 | -104 | N/A |
3/31/2021 | 1 | -114 | -82 | -80 | N/A |
12/31/2020 | 1 | -82 | -57 | -56 | N/A |
9/30/2020 | N/A | -52 | -19 | -19 | N/A |
6/30/2020 | N/A | -54 | -17 | -16 | N/A |
3/31/2020 | N/A | -48 | -16 | -15 | N/A |
12/31/2019 | N/A | -47 | -14 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 290A is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 290A is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 290A is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 290A's revenue (63.8% per year) is forecast to grow faster than the German market (3.9% per year).
High Growth Revenue: 290A's revenue (63.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 290A's Return on Equity is forecast to be high in 3 years time